Tag: VEITH TV
VEITH 2019: Tackling dehydration has a “tremendous impact” when treating claudication...
Enrico Ascher (New York, USA) interviews Juan Parodi (Buenos Aires, Argentina) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA), about his research on claudication therapy.
Parodi explains...
VEITH 2019: “It was like the wild west”: Hazim Safi takes...
Nick Cheshire (London, UK) interviews Hazim Safi (Houston, USA) for VEITHtv at VEITH 2019 (19–23 November, New York, USA) about his early training, which Safi describes as being...
VEITH 2019: “Light at the end of the tunnel” following paclitaxel...
Sean Lyden (Cleveland, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA) about the “tumultuous” year for the industry following the publication of the...
VEITH 2019: Paclitaxel controversy propels innovation in endovascular BTK treatment
Juan Granada (New York, USA) chats to Sahil Parikh (New York, USA) for VEITHtv about below-the-knee (BTK) intervention and innovation and how the paclitaxel controversy has...
TCAR a “phenomenal alternative” to carotid endarterectomy for high-risk patients
Keith Calligaro (Philadelphia, USA) interviews Vikram Kashyap (Cleveland, USA) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA) about whether transcarotid artery revascularisation (TCAR) might replace carotid...
Physicians “must weigh long-term outcomes” against “short-term benefits” for aortic repair...
Enrico Ascher (New York, USA) interviews Mark Farber (Chapel Hill, USA) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA) about the differences between off-the-shelf (OTS) devices...
Trials needed to assess whether metformin impedes aneurysm progression in non-diabetic...
Ronald Dalman (Stanford, USA) and Kak Khee Yeung (Amsterdam, The Netherlands) talk to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA) about how the use of...
High-quality evidence from multiple sources “key” to holistic assessment of endograft...
Matt Thompson (Irvine, USA) talks to VEITHtv about his role, as chief medical officer at Endologix, in assessing the diverse portfolio of endografts and their performance.
Thompson...
IVL has “changed the dynamics” of facilitating EVAR & TEVAR in...
Frank Arko (Charlotte, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA), about the benefits of using Shockwave Intravascular Lithotripsy (IVL) when performing EVAR...
LEOPARD trial three-year data provide head-to-head comparison of AFX2 with other...
Christopher Kwolek (Boston, USA) talks to VEITHtv about the “truly revolutionary” LEOPARD trial which evaluated the AFX EVAR AAA Graft System (Endologix) with anatomical fixation against...
EVAR before, and EVAR after: VEITHtv looks back with the pioneers
Enrico Ascher (New York, USA) interviews endovascular pioneers Juan Parodi (Buenos Aires, Argentina) and Frank Veith (New York, USA) about the early days of endovascular aortic...
Slow rebalancing, not “seismic overnight change” in practice expected after NICE...
Nick Cheshire (London, UK) interviews Andrew Bradbury (Birmingham, UK) for VEITHtv at VEITH 2019 (19–23 November, New York, USA) about the draft National Institute for Health and Care...
VEITH 2019: Fiber Optic RealShape (FORS) technology could spark a new...
Joost van Herwaarden (Utrecht, The Netherlands) and Tilo Kölbel (Hamburg, Germany) discuss the current challenges of image-guided therapy—primarily regarding the limiting factor of having...
